HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta-Endorphin. Opiate receptor-binding activity of synthetic analogs modified in the enkephalin segment in rat brain membrane and neuroblastoma x glioma hybrid cell.

Abstract
The potency of a series of synthetic analogs of beta-endorphin in inhibiting binding of [3H2-Tyr27]-beta h-endorphin to either rat brain membranes or neuroblastoma x glioma hybrid cells (NG108-15) has been determined and compared with the previously determined analgesic potency. There is a very good correlation between inhibitory potency in membranes and cells, but the correlation between analgesic potency and inhibitory potency in either membranes or cells is not as good.
AuthorsR G Hammonds Jr, C H Li
JournalInternational journal of peptide and protein research (Int J Pept Protein Res) Vol. 19 Issue 3 Pg. 254-8 (Mar 1982) ISSN: 0367-8377 [Print] Denmark
PMID6288587 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Endorphins
  • Receptors, Opioid
  • beta-Endorphin
Topics
  • Animals
  • Brain (metabolism)
  • Cell Membrane (metabolism)
  • Endorphins (metabolism)
  • Glioma (metabolism)
  • Hybrid Cells (metabolism)
  • Kinetics
  • Mice
  • Neuroblastoma (metabolism)
  • Rats
  • Receptors, Opioid (metabolism)
  • Structure-Activity Relationship
  • beta-Endorphin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: